Remedy

Genetics & Origin

Remedy is a deliberate pharmaceutical-grade cross produced by Barcelona's Resin Seeds, the team responsible for popularising CBD-rich cannabis in the modern market. By pairing Cannatonic — their landmark high-CBD mother — with an Afghani Skunk male, Resin Seeds injected robust body mass and structural resilience into an otherwise finicky CBD phenotype. The result stabilises the CBD-dominant chemotype through successive backcross generations, ensuring that commercial batches reliably express 12–15% CBD and sub-1% THC without the hit-or-miss ratio variability seen in earlier Cannatonic phenos.

The Afghani Skunk parentage contributes a compact indica-leaning structure with dense, resinous colas, a slightly faster flowering window than pure Cannatonic, and added cold tolerance — expanding Remedy's viable cultivation geography into northern European and high-altitude North American climates. The resulting plant is both medicinally potent and agronomically practical, an important combination for small-scale medical cultivators.

Genetic Lineage Data

Terpene Profile & Aroma

Remedy's aroma is quietly complex — not the loud fruit-forward assault of high-THC commercial cultivars but a refined, botanical medley of damp earth, fresh pine, lemon zest, and a whisper of sweet florals. This character is driven by a myrcene-forward terpene stack that positions the strain firmly in the functional-wellness category of the fragrance spectrum. The scent deepens when buds are broken open, releasing an almost herbaceous pine-resin note that experienced users often describe as reminiscent of a forest floor after rain.

From a pharmacological standpoint, Remedy's terpene combination is arguably as important as its CBD content. Myrcene enhances CBD's membrane permeability, potentially improving bioavailability. Caryophyllene binds CB2 receptors directly, adding a cannabinoid-like anti-inflammatory layer. Pinene counters any drowsiness tendency and may support bronchodilation — a useful property for patients medicating respiratory-adjacent conditions.

Comparison with Similar CBD Strains

Effects & Medical Applications

Unlike psychoactive cannabis strains where effects ramp up quickly and can overwhelm sensitive users, Remedy delivers a gradual, wave-like onset of physical relaxation and mental calm that settles in over 15–30 minutes without any perceptible ceiling. Users consistently report feeling relaxed yet clear-headed — the hallmark feature that distinguishes well-bred CBD strains from their THC-dominant counterparts. Functional cognition is preserved, making Remedy compatible with tasks requiring sustained concentration, fine motor work, and social interaction.

In clinical settings, Remedy is most frequently prescribed for chronic nociceptive and neuropathic pain, where its combination of high CBD and caryophyllene creates overlapping analgesic pathways. Anxiety and PTSD patients report meaningful symptom attenuation without the paradoxical anxiety that high-THC strains sometimes trigger. Neurological applications — particularly intractable epilepsy — represent another key use case, and several anecdotal reports from Dravet syndrome families cite Remedy as an effective seizure-frequency reducer in adults unable to access pharmaceutical CBD isolate.

Grow Guide

Remedy is a beginner-accessible strain with a forgiving temperament inherited from its Afghani Skunk lineage. It thrives in both soil and coco/perlite mixes, responds well to light defoliation during mid-veg, and maintains a compact profile that suits space-constrained indoor grows. Outdoor plants in Mediterranean and Pacific Northwest climates develop notably larger yields while still finishing before first frost in most temperate regions. The stable CBD genetics mean phenotypic variation is minimal — growers can expect consistent chemotype expression across a full crop without extensive pheno-hunting.